NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression

Abstract Background Depression has been recognized as a leading global contributor to disease burden and mortality. While the etiology of depression involves a complex interplay of biological, psychological, and social factors, its precise pathophysiological mechanisms remain incompletely understood...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing-Zhong Li, Jia-Xin Tan, Guo-Tian Ruan, Quan-Zhi Qin, Teng Deng, Yi-Zhen Gong
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s12888-025-07082-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402035464568832
author Qing-Zhong Li
Jia-Xin Tan
Guo-Tian Ruan
Quan-Zhi Qin
Teng Deng
Yi-Zhen Gong
author_facet Qing-Zhong Li
Jia-Xin Tan
Guo-Tian Ruan
Quan-Zhi Qin
Teng Deng
Yi-Zhen Gong
author_sort Qing-Zhong Li
collection DOAJ
description Abstract Background Depression has been recognized as a leading global contributor to disease burden and mortality. While the etiology of depression involves a complex interplay of biological, psychological, and social factors, its precise pathophysiological mechanisms remain incompletely understood. The albumin-bilirubin (ALBI) score, originally developed as an objective measure of hepatic function, has demonstrated prognostic value in diverse clinical contexts including liver diseases, brain tumors and chronic heart failure. However, the relationship between ALBI scores and depression has not been systematically investigated. This study aims to examine the association between ALBI scores and depression in a nationally representative cohort. Methods This population-based cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) spanning seven survey cycles (2005–2018). The ALBI score was calculated using the established formula: ALBI = (log10 bilirubin [μmol/L] × 0.66) + (albumin [g/L] × -0.085). Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Weighted multivariable logistic regression models were constructed to analyze the association between ALBI and depression, adjusting for potential covariates. Nonlinear relationships were explored using restricted cubic splines (RCS). The robustness of the results was validated through subgroup analyses. The relationship between ALBI and depression symptoms severity was evaluated via ANOVA. For prognostic analysis, Cox proportional hazards regression models assessed the link between ALBI and clinical outcomes, complemented by Kaplan–Meier (K-M) survival curves and RCS plots to illustrate trends. Results Weighted multivariable logistic regression models revealed a significant association between elevated ALBI scores and depression risk. Participants in the higher ALBI (ALBI≧ -2.87) demonstrated 16% increased odds of depression compared to the reference (ALBI < -2.87) (adjusted OR = 1.16, 95% CI 1.03–1.31, P = 0.01). Restricted cubic spline analysis confirmed a linear relationship between continuous ALBI scores and depression risk. Subgroup analyses stratified by age, gender, race, education, smoking, drinking and diabetes consistently identified high ALBI as an independent risk factor for depression. The analysis of variance revealed a significant dose–response relationship between ALBI and depression symptom severity (P < 0.05). Cox proportional hazards models revealed significant associations between ALBI increments and mortality risks in the depression cohort. For all-cause mortality, each 1-unit ALBI elevation was associated with a 284% increased risk (adjusted HR = 3.84, 95% CI 2.77–5.33, P < 0.01). Cancer-related mortality showed a 235% risk escalation per ALBI unit (HR = 3.35, 95% CI 1.54–7.26, P < 0.01), while non-cancer deaths exhibited an stronger association at 296% increased risk (HR = 3.96, 95% CI 2.76–5.67, P < 0.01). Conclusion By analyzing data from seven cycles (2005–2018) of the NHANES database, this study identified a positive association between the ALBI score and depression among U.S. adults. The ALBI score was also linked to the severity of depressive symptoms, and was associated with all-cause mortality, cancer-related mortality in individuals with depression. Trial registration Clinical trial number: not applicable.
format Article
id doaj-art-fa995ed2b7a041e69d65d33281cd76eb
institution Kabale University
issn 1471-244X
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Psychiatry
spelling doaj-art-fa995ed2b7a041e69d65d33281cd76eb2025-08-20T03:37:38ZengBMCBMC Psychiatry1471-244X2025-07-0125111010.1186/s12888-025-07082-xNHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depressionQing-Zhong Li0Jia-Xin Tan1Guo-Tian Ruan2Quan-Zhi Qin3Teng Deng4Yi-Zhen Gong5Guangxi Medical University Cancer HospitalGuangxi Medical University Cancer HospitalDepartment of General Surgery, Beijing Friendship Hospital, Capital Medical UniversityGuangxi Medical University Cancer HospitalGuangxi Medical University Cancer HospitalGuangxi Medical University Cancer HospitalAbstract Background Depression has been recognized as a leading global contributor to disease burden and mortality. While the etiology of depression involves a complex interplay of biological, psychological, and social factors, its precise pathophysiological mechanisms remain incompletely understood. The albumin-bilirubin (ALBI) score, originally developed as an objective measure of hepatic function, has demonstrated prognostic value in diverse clinical contexts including liver diseases, brain tumors and chronic heart failure. However, the relationship between ALBI scores and depression has not been systematically investigated. This study aims to examine the association between ALBI scores and depression in a nationally representative cohort. Methods This population-based cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) spanning seven survey cycles (2005–2018). The ALBI score was calculated using the established formula: ALBI = (log10 bilirubin [μmol/L] × 0.66) + (albumin [g/L] × -0.085). Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Weighted multivariable logistic regression models were constructed to analyze the association between ALBI and depression, adjusting for potential covariates. Nonlinear relationships were explored using restricted cubic splines (RCS). The robustness of the results was validated through subgroup analyses. The relationship between ALBI and depression symptoms severity was evaluated via ANOVA. For prognostic analysis, Cox proportional hazards regression models assessed the link between ALBI and clinical outcomes, complemented by Kaplan–Meier (K-M) survival curves and RCS plots to illustrate trends. Results Weighted multivariable logistic regression models revealed a significant association between elevated ALBI scores and depression risk. Participants in the higher ALBI (ALBI≧ -2.87) demonstrated 16% increased odds of depression compared to the reference (ALBI < -2.87) (adjusted OR = 1.16, 95% CI 1.03–1.31, P = 0.01). Restricted cubic spline analysis confirmed a linear relationship between continuous ALBI scores and depression risk. Subgroup analyses stratified by age, gender, race, education, smoking, drinking and diabetes consistently identified high ALBI as an independent risk factor for depression. The analysis of variance revealed a significant dose–response relationship between ALBI and depression symptom severity (P < 0.05). Cox proportional hazards models revealed significant associations between ALBI increments and mortality risks in the depression cohort. For all-cause mortality, each 1-unit ALBI elevation was associated with a 284% increased risk (adjusted HR = 3.84, 95% CI 2.77–5.33, P < 0.01). Cancer-related mortality showed a 235% risk escalation per ALBI unit (HR = 3.35, 95% CI 1.54–7.26, P < 0.01), while non-cancer deaths exhibited an stronger association at 296% increased risk (HR = 3.96, 95% CI 2.76–5.67, P < 0.01). Conclusion By analyzing data from seven cycles (2005–2018) of the NHANES database, this study identified a positive association between the ALBI score and depression among U.S. adults. The ALBI score was also linked to the severity of depressive symptoms, and was associated with all-cause mortality, cancer-related mortality in individuals with depression. Trial registration Clinical trial number: not applicable.https://doi.org/10.1186/s12888-025-07082-xAlbumin-bilirubin scoreDepressionNHANES
spellingShingle Qing-Zhong Li
Jia-Xin Tan
Guo-Tian Ruan
Quan-Zhi Qin
Teng Deng
Yi-Zhen Gong
NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression
BMC Psychiatry
Albumin-bilirubin score
Depression
NHANES
title NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression
title_full NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression
title_fullStr NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression
title_full_unstemmed NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression
title_short NHANES 2005–2018 data reveal high albumin-bilirubin scores are associated with depression
title_sort nhanes 2005 2018 data reveal high albumin bilirubin scores are associated with depression
topic Albumin-bilirubin score
Depression
NHANES
url https://doi.org/10.1186/s12888-025-07082-x
work_keys_str_mv AT qingzhongli nhanes20052018datarevealhighalbuminbilirubinscoresareassociatedwithdepression
AT jiaxintan nhanes20052018datarevealhighalbuminbilirubinscoresareassociatedwithdepression
AT guotianruan nhanes20052018datarevealhighalbuminbilirubinscoresareassociatedwithdepression
AT quanzhiqin nhanes20052018datarevealhighalbuminbilirubinscoresareassociatedwithdepression
AT tengdeng nhanes20052018datarevealhighalbuminbilirubinscoresareassociatedwithdepression
AT yizhengong nhanes20052018datarevealhighalbuminbilirubinscoresareassociatedwithdepression